Crystallized phenol

PreclinicalSmall molecule

SSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Crystallized phenol is one of 6 small molecule programs targeting Pilonidal sinus. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pilonidal SinusActive, not recruiting

Pilonidal SinusPreclinical

Active, not recruiting

Competition

Competitive Landscape

9 competitors in Pilonidal Sinus

#DrugCompanyPhaseTrials

Flagyl

DDePuy Orthopaedics

Approved

—2

Silver Nitrate

MMansoura University Hospital

Approved

1 3

Phenol

NNorthwestern University

Approved

1 4

Xylocaine

MMEDRx USA, Inc.

Preclinical

1 5

Platelet Rich Plasma

ZZagazig University

Preclinical

1 6

Crystallized phenol

SSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prospective1 trial

Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective Study

Unknown status·SS.B. Konya Education and Research Hospital·N/A·NCT01792557·200 enrolled

Pilonidal sinus1 trial

Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus

Recruiting·SSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital·N/A·NCT07023952·130 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Crystallized phenol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Crystallized phenol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Crystallized phenol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Crystallized phenol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prospective1 trial

Pilonidal sinus1 trial

References

Drug Info

Quick Facts

Related News